Acurx Pharmaceuticals Inc (ACXP) Shares Down Despite Recent Market Volatility

The stock price of Acurx Pharmaceuticals Inc (NASDAQ: ACXP) has dropped by -7.83 compared to previous close of 2.17. Despite this, the company has seen a fall of -3.85% in its stock price over the last five trading days. Seeking Alpha reported 2024-03-18 that Acurx Pharmaceuticals, Inc. (ACXP) Q4 2023 Earnings Call Transcript

Is It Worth Investing in Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Right Now?

The 36-month beta value for ACXP is also noteworthy at -1.87. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for ACXP is 11.94M, and at present, short sellers hold a 2.47% of that float. The average trading volume of ACXP on April 04, 2024 was 176.78K shares.

ACXP’s Market Performance

ACXP stock saw a decrease of -3.85% in the past week, with a monthly decline of -31.74% and a quarterly a decrease of -50.00%. The volatility ratio for the week is 10.05%, and the volatility levels for the last 30 days are 8.72% for Acurx Pharmaceuticals Inc (ACXP). The simple moving average for the past 20 days is -20.02% for ACXP’s stock, with a -32.20% simple moving average for the past 200 days.

ACXP Trading at -32.04% from the 50-Day Moving Average

After a stumble in the market that brought ACXP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.32% of loss for the given period.

Volatility was left at 8.72%, however, over the last 30 days, the volatility rate increased by 10.05%, as shares sank -33.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -49.24% lower at present.

During the last 5 trading sessions, ACXP fell by -3.85%, which changed the moving average for the period of 200-days by -27.27% in comparison to the 20-day moving average, which settled at $2.45. In addition, Acurx Pharmaceuticals Inc saw -47.78% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for ACXP

The total capital return value is set at -740.65. Equity return is now at value -243.33, with -170.64 for asset returns.

Currently, EBITDA for the company is -14.58 million with net debt to EBITDA at 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.53.

Conclusion

In summary, Acurx Pharmaceuticals Inc (ACXP) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts